MedElevator Войти в исследования
← Поиск публикаций

DOI 10.21873/invivo.14413

Медицинская библиотека · In vivo (Athens, Greece) · 2026

Pan-cancer Evaluation of the Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker Across Six Major Solid Tumors.

Cai Guilan, Zhang Xiao, Zhang Heyang, Shi Hanping

СтатьяПеревод в очереди

Аннотация

BACKGROUND/AIM: Systemic inflammation is increasingly recognized as a key hallmark of cancer progression and an important determinant of patient outcomes, reflecting the balance between tumor-promoting inflammatory activity and anti-tumor immune competence. Using routinely available peripheral blood counts, we evaluated the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) across several common malignancies and developed a pragmatic model for overall survival risk estimation.

PATIENTS AND

METHODS

From the INSCOC registry, 14,425 patients with lung, gastric, colorectal, liver, brain, or breast cancer were included and randomly split (10,098/4,327) into training and validation sets. Six inflammation-based indices from neutrophil, lymphocyte, and platelet counts were compared for overall survival (OS) using Harrell's C-index and time-dependent receiver operating characteristic (ROC) curves. Associations between NLR and OS were tested by Kaplan-Meier curves, restricted cubic splines, and multivariable Cox models adjusted for demographic, clinical, and treatment factors. A nomogram incorporating NLR and selected routinely available clinical variables was developed and internally evaluated by calibration analysis.

RESULTS

NLR showed the highest, though modest, discrimination across all six cancers (C-index ~0.53-0.63). A threshold of 3.38 identified patients with significantly shorter OS in both sets (log-rank p<0.001). The risk increased progressively with higher NLR and remained significant after multivariable adjustment. Associations were broadly consistent across age, sex, comorbidity, and treatment subgroups. The NLR-based nomogram showed generally acceptable calibration for estimating 1-, 3-, and 5-year survival.

CONCLUSION

Elevated NLR independently signals worse survival across several major solid tumors and showed higher prognostic discrimination than other evaluated inflammation-derived indices. The proposed nomogram may provide a simple, clinically applicable tool to support individualized risk stratification using routinely available data.

Для цитирования: Cai Guilan, Zhang Xiao, Zhang Heyang, Shi Hanping. Pan-cancer Evaluation of the Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker Across Six Major Solid Tumors.. In vivo (Athens, Greece). 2026. DOI: 10.21873/invivo.14413.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.